The global saltidin market is estimated to be valued at nearly USD 2.5 billion by 2030. Increasing awareness about diseases and insects transmitted through bites will drive the growth of this market over the forecast period. The high-end segment is projected to grow at a CAGR of 6.3% from 2021-2030, with North America as its largest regional share contributor due in part to higher adoption of insect repellents in this region as compared with others owing to climate change and population density.
Global saltidin (Picaridin &Icaridin) Market by Type (High Purity, Low Purity), By Application (Insect Repellents) And By Region - Forecast From 2021 To 2030.
Million USD %CAGR 2021* 2022* 2023* 2024* 2025* 2026* 2027* 2030** High purity 2,140 1,820 1,890 1,980 2 110 2 240 2 520 3 780 5 110 Low purity 835 770 750 760 800 870 930 970 950 710 Total Market 3135 2790 2860 2950 3080 3130 3280 3400 3810 4610 CAGR (%) -6.9% -5% 0% 4% 6% 5% 4% 4% 6%.3%.0.
The insect repellents segment is projected to grow at the highest CAGR of 7.4% from 2021-2030, primarily attributed to emerging applications for vector control and repelling mosquitoes.
The high purity saltidin is estimated to account for nearly 60% of the total market in 2030 owing to its higher efficacy as an insect repellent. This segment has been witnessing a healthy growth rate over the last few years, due to its effectiveness against pests such as mosquitoes and flies. However, it accounts for a smaller share of the overall industry volume currently because of strict regulatory guidelines governing its production process.
North America was ranked as the leading regional market in terms of value in 2018, with more than one-fourth share attributable to this region; it will continue holding on this position till 2030 owing to advances made by local manufacturers increasing awareness about insects transmitted through bites and climate change driving increase in demand for insect repellents products.
Industry Growth Insights published a new data on “Saltidin (Picaridin &Icaridin) Market”. The research report is titled “Saltidin (Picaridin &Icaridin) Market research by Types (High Purity, Low Purity), By Applications (Insect Repellents, Others), By Players/Companies Saltigo Fine Chemicals, LANXESS Corporation, Cayman, NeoBioscience Technology, MaiBio Co Ltd, Easy Life Bioscience LLC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Saltidin (Picaridin &Icaridin) Market Research Report
By Type
High Purity, Low Purity
By Application
Insect Repellents, Others
By Companies
Saltigo Fine Chemicals, LANXESS Corporation, Cayman, NeoBioscience Technology, MaiBio Co Ltd, Easy Life Bioscience LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Saltidin (Picaridin &Icaridin) Market Report Segments:
The global Saltidin (Picaridin &Icaridin) market is segmented on the basis of:
Types
High Purity, Low Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Insect Repellents, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Saltigo Fine Chemicals
- LANXESS Corporation
- Cayman
- NeoBioscience Technology
- MaiBio Co Ltd
- Easy Life Bioscience LLC
 Market Overview.svg)
Highlights of The Saltidin (Picaridin &Icaridin) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High Purity
- Low Purity
- By Application:
- Insect Repellents
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Saltidin (Picaridin &Icaridin) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Saltidin (picaridin & Icaridin) is a combination of two active ingredients, picaridin and icaridine. These ingredients are found in many over-the-counter pain relievers, such as ibuprofen and acetaminophen. Saltidin is used to relieve pain from headaches, toothaches, menstrual cramps, arthritis symptoms, or other types of pain.
Some of the major players in the saltidin (picaridin &icaridin) market are Saltigo Fine Chemicals, LANXESS Corporation, Cayman, NeoBioscience Technology, MaiBio Co Ltd, Easy Life Bioscience LLC.
The saltidin (picaridin &icaridin) market is expected to register a CAGR of 6.3%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Saltidin (Picaridin &Icaridin) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Saltidin (Picaridin &Icaridin) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Saltidin (Picaridin &Icaridin) Market - Supply Chain
4.5. Global Saltidin (Picaridin &Icaridin) Market Forecast
4.5.1. Saltidin (Picaridin &Icaridin) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Saltidin (Picaridin &Icaridin) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Saltidin (Picaridin &Icaridin) Market Absolute $ Opportunity
5. Global Saltidin (Picaridin &Icaridin) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Type
5.3.1. High Purity
5.3.2. Low Purity
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Saltidin (Picaridin &Icaridin) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Application
6.3.1. Insect Repellents
6.3.2. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Saltidin (Picaridin &Icaridin) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Saltidin (Picaridin &Icaridin) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Saltidin (Picaridin &Icaridin) Demand Share Forecast, 2019-2026
9. North America Saltidin (Picaridin &Icaridin) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Application
9.4.1. Insect Repellents
9.4.2. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Type
9.7.1. High Purity
9.7.2. Low Purity
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Saltidin (Picaridin &Icaridin) Demand Share Forecast, 2019-2026
10. Latin America Saltidin (Picaridin &Icaridin) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Application
10.4.1. Insect Repellents
10.4.2. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Type
10.7.1. High Purity
10.7.2. Low Purity
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Saltidin (Picaridin &Icaridin) Demand Share Forecast, 2019-2026
11. Europe Saltidin (Picaridin &Icaridin) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Application
11.4.1. Insect Repellents
11.4.2. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Type
11.7.1. High Purity
11.7.2. Low Purity
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Saltidin (Picaridin &Icaridin) Demand Share, 2019-2026
12. Asia Pacific Saltidin (Picaridin &Icaridin) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Application
12.4.1. Insect Repellents
12.4.2. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Type
12.7.1. High Purity
12.7.2. Low Purity
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Saltidin (Picaridin &Icaridin) Demand Share, 2019-2026
13. Middle East & Africa Saltidin (Picaridin &Icaridin) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Application
13.4.1. Insect Repellents
13.4.2. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Saltidin (Picaridin &Icaridin) Market Size and Volume Forecast by Type
13.7.1. High Purity
13.7.2. Low Purity
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Saltidin (Picaridin &Icaridin) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Saltidin (Picaridin &Icaridin) Market: Market Share Analysis
14.2. Saltidin (Picaridin &Icaridin) Distributors and Customers
14.3. Saltidin (Picaridin &Icaridin) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Saltigo Fine Chemicals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. LANXESS Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cayman
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. NeoBioscience Technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MaiBio Co Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Easy Life Bioscience LLC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
